Video

Pharmacist Medication Insights: Vibegron for Overactive Bladder

Gemtesa (vibegron; Urovant Sciences) tablets are approved to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Gemtesa (vibegron; Urovant Sciences) tablets are indicated to treat overactive bladder (OAB) with symptoms of urge urinary incontinence (UUI), urgency, and urinary frequency.

OAB results from the involuntary contraction of the detrusor. Symptoms can include a sudden urge to urinate that is difficult to control, unintentional loss of urine immediately after an urgent need to urinate, urinating 8 or more times in 24 hours, and waking more than twice nightly to urinate.

OAB affects more than 30 million adults in the United States and often significantly affects daily activities.

Related Videos
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Image Credit: © Krakenimages.com - stock.adobe.com
Young female pharmacist working in her large pharmacy. Placing medications, taking inventory. Lifestyle - Image credit: lubero | stock.adobe.com
Pharmacist helping patient -- Image credit: Clayton D/peopleimages.com | stock.adobe.com
Pharmacist and a patient -- Image credit: Zamrznuti tonovi | stock.adobe.com
American Pharmacist Month | Image Credit: Zoran Zeremski - stock.adobe.com
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy School, social media, non-traditional learning | Image Credit: Ахтем - stock.adobe.com